214 related articles for article (PubMed ID: 31939903)
1. Complementary role of 18F-FDG PET/CT for sentinel lymph node algorithm in endometrial cancer with high-risk factors for lymphatic metastasis.
Taşkin S; Varli B; Ersöz CC; Altin D; Soydal Ç; Ortaç F
Nucl Med Commun; 2020 Apr; 41(4):389-394. PubMed ID: 31939903
[TBL] [Abstract][Full Text] [Related]
2. Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients.
Crivellaro C; Landoni C; Elisei F; Buda A; Bonacina M; Grassi T; Monaco L; Giuliani D; Gotuzzo I; Magni S; Di Martino G; Delle Marchette M; Guerra L; Landoni F; Fruscio R; Messa C; De Bernardi E
Int J Gynecol Cancer; 2020 Mar; 30(3):378-382. PubMed ID: 32079712
[TBL] [Abstract][Full Text] [Related]
3.
Mayoral M; Paredes P; Domènech B; Fusté P; Vidal-Sicart S; Tapias A; Torné A; Pahisa J; Ordi J; Pons F; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):20-26. PubMed ID: 27667001
[TBL] [Abstract][Full Text] [Related]
4. The Combination of Preoperative Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Mapping in the Surgical Management of Endometrioid Endometrial Cancer.
Bese T; Sal V; Demirkiran F; Kahramanoglu I; Tokgozoglu N; Ilvan S; Aydin O; Hallac M; Vatankulu B; Demirayak G; Turan H; Arvas M
Int J Gynecol Cancer; 2016 Sep; 26(7):1228-38. PubMed ID: 27643647
[TBL] [Abstract][Full Text] [Related]
5. Assessing
Sarikaya I; Sarikaya A
J Nucl Med Technol; 2019 Jun; 47(2):149-153. PubMed ID: 30413593
[No Abstract] [Full Text] [Related]
6. Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and Sentinel Lymph Node Biopsy in Endometrial Cancer Patients: A Prospective Study.
Palaia I; Di Donato V; Musella A; Di Pinto A; Santangelo G; Petriglia G; Benedetti Panici P
J Invest Surg; 2021 Jun; 34(6):672-676. PubMed ID: 31647346
[TBL] [Abstract][Full Text] [Related]
7. Initial experience with positron emission tomography/computed tomography in addition to computed tomography and magnetic resonance imaging in preoperative risk assessment of endometrial cancer patients.
Nordskar NJ; Hagen B; Ogarkov A; Vesterfjell EV; Salvesen Ø; Aune G
Eur J Obstet Gynecol Reprod Biol; 2021 Apr; 259():46-52. PubMed ID: 33582479
[TBL] [Abstract][Full Text] [Related]
8. Sentinel lymph node biopsy in early stage endometrial cancer: a Turkish gynecologic oncology group study (TRSGO-SLN-001).
Taşkın S; Altin D; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Kahramanoglu I; Naki MM; Güngör M; Köse F; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Mar; 30(3):299-304. PubMed ID: 31857440
[TBL] [Abstract][Full Text] [Related]
9. Usefulness and potential pitfalls of pre-operative PET-CT in patients with endometrial cancer undergoing one- and two-step sentinel lymph node mapping: Do negative findings on PET-CT negativity really indicate node negativity?
Kim YN; Lee D; Cha J; Kang WJ; Lee YJ; Lee JY; Nam EJ; Kim S; Kim YT; Kim SW
Gynecol Oncol; 2022 Sep; 166(3):438-443. PubMed ID: 35907682
[TBL] [Abstract][Full Text] [Related]
10. Preoperative 18F-Fluorodeoxyglucose Positron Emission Tomography/CT in Prediction of Uterine Risk Factors and Lymph Node Metastasis: An Analysis of 111 Endometrioid Endometrial Cancer Patients.
Konuralp Atakul B; Taşkın S; Soydal Ç; Sükür YE; Kahraman A; Koyuncu K; İbiş E; Ortac F
Gynecol Obstet Invest; 2017; 82(4):340-348. PubMed ID: 27771729
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic accuracy of fluorodeoxyglucose-positron emission tomography/computed tomography and sentinel node biopsy in the prediction of pelvic lymph node metastasis in patients with endometrial cancer: A retrospective observational study.
Tanaka T; Terai Y; Yamamoto K; Yamada T; Ohmichi M
Medicine (Baltimore); 2018 Sep; 97(38):e12522. PubMed ID: 30235772
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic accuracy of preoperative
Hu J; Zhang K; Yan Y; Zang Y; Wang Y; Xue F
Arch Gynecol Obstet; 2019 Sep; 300(3):519-529. PubMed ID: 31165242
[TBL] [Abstract][Full Text] [Related]
13. Value and best way for detection of Sentinel lymph node in early stage endometrial cancer: Selective lymphadenectomy algorithm.
El-Agwany AS; Meleis MH
Eur J Obstet Gynecol Reprod Biol; 2018 Jun; 225():35-39. PubMed ID: 29660577
[TBL] [Abstract][Full Text] [Related]
14. Role of the integrated FDG PET/CT in the surgical management of patients with high risk clinical early stage endometrial cancer: detection of pelvic nodal metastases.
Signorelli M; Guerra L; Buda A; Picchio M; Mangili G; Dell'Anna T; Sironi S; Messa C
Gynecol Oncol; 2009 Nov; 115(2):231-5. PubMed ID: 19695685
[TBL] [Abstract][Full Text] [Related]
15. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
[TBL] [Abstract][Full Text] [Related]
16. A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer.
Aşıcıoğlu O; Gungorduk K; Ozdemir A; Güngördük Ö; Gokçü M; Yaşar L; Sancı M
J Obstet Gynaecol; 2019 Jan; 39(1):105-109. PubMed ID: 30187784
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node mapping in early-stage cervical cancer - A national prospective multicenter study (SENTIREC trial).
Sponholtz SE; Mogensen O; Hildebrandt MG; Schledermann D; Parner E; Markauskas A; Frøding LP; Fuglsang K; Vilstrup MH; Bjørnholt SM; Jensen PT
Gynecol Oncol; 2021 Sep; 162(3):546-554. PubMed ID: 34226018
[TBL] [Abstract][Full Text] [Related]
18. Paraaortic sentinel lymph node detection in intermediate and high-risk endometrial cancer by transvaginal ultrasound-guided myometrial injection of radiotracer (TUMIR).
Angeles MA; Migliorelli F; Vidal-Sicart S; Saco A; Ordi J; Ros C; Fusté P; Munmany M; Escura S; Carreras N; Sánchez-Izquierdo N; Pahisa J; Torné A; Paredes P; Del Pino M
J Gynecol Oncol; 2021 Jul; 32(4):e52. PubMed ID: 33908710
[TBL] [Abstract][Full Text] [Related]
19. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002).
Altin D; Taşkın S; Kahramanoglu I; Vatansever D; Tokgozoglu N; Karabük E; Turan H; Takmaz Ö; Naki MM; Güngör M; Köse MF; Ortac F; Arvas M; Ayhan A; Taskiran C
Int J Gynecol Cancer; 2020 Jul; 30(7):1005-1011. PubMed ID: 32474451
[TBL] [Abstract][Full Text] [Related]
20. Preoperative PET/CT does not accurately detect extrauterine disease in patients with newly diagnosed high-risk endometrial cancer: A prospective study.
Stewart KI; Chasen B; Erwin W; Fleming N; Westin SN; Dioun S; Frumovitz M; Ramirez PT; Lu KH; Wong F; Aloia TA; Soliman PT
Cancer; 2019 Oct; 125(19):3347-3353. PubMed ID: 31225906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
